Angiotensin Converting Enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment

International Journal of Geriatric Psychiatry

Volumn 21, Issue 6, 2006, Pages 550-555

  Rozzini, Luca ^a,b   Chilovi, Barbara Vicini ^a,b   Bertoletti, Erik ^a   Conti, Marta ^a   Del Rio, Ilenia ^a   Trabucchi, Marco ^b   Padovani, Alessandro ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b GERIATRIC RESEARCH GROUP   (Italy)

Author keywords

Angiotensin converting enzyme (ACE) inhibitors; Homocysteine, education; Memory decline; Mild cognitive impairment

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HOMOCYSTEINE;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CLASSIFICATION; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG MECHANISM; EDUCATION; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PRESCRIPTION; RISK FACTOR; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COGNITION DISORDERS; DEMENTIA; DISEASE PROGRESSION; EDUCATIONAL STATUS; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 33745883524     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1523     Document Type: Article

References (44)

1. Amieva H, Jacqmin-Gadda H, Orgogozo JM, et al. 2005. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain 128: 1093-1101.
2. Amieva H, Letenneur L, Dartigues JF, et al. 2004. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord 18(1): 87-93.
3. Artero S, Tierney MC, Touchon J, et al. 2003. Prediction of transition from cognitive impairment to senile dementia: a prospective, longitudinal study. Acta Psychiatr Scand 107(5): 390-393.
4. Barnes NM, Cheng CHK, Costal B, et al. 1991. Angiotensin converting enzime density is increased in temporal cortex from patients with Alzheimer's disease. Eur J Pharmacol 200: 289-292.
5. Bennet DA. 2003. Update on mild cognitive impairment. Curr Neurol Neurosci Rep 3(5): 379-384.
6. Birkenhager WH, Forette F, Staessen JA. 2004. Dementia and antihypertensive treatment. Curr Opin Nephrol Hypertens 13(2): 225-230.
7. Bozoki A, Giordani B, Heidebrink JL, et al. 2001. Mild Cognitive Impairment predict dementia in non demented elderly patients with memory loss. Arch Neurol 58: 411-416.
8. Busse A, Bischkopf J, Riedel-Heller SG, et al. 2003. Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry 182: 449-454.
9. Chen P, Ratcliff G, Phil D, et al. 2000. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 55: 1847-1853.
10. Cummings JL, Mega M, Gray K, et al. 1994. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308-2314.
11. Devanand DP, Folz M, Gorlyn M, et al. 1997. Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 45(3): 321-328.
12. Fahn S, Elton RL. 1987. Members of the UPDRS development committee: unified Parkinson's disease rating scale. In Recent developments in Parkinson's disease, Fahn S, Marsden CD, Calne DB, Goldstein M (eds). MacMillan Healthcare Information: Florham Park, NJ; 153-304.
13. Fioravanti M, Nacca D, Buckley AE. 1994. The Italian version of Alzheimer's Disease Assessment Scale (ADAS): psychometric and normative characteristics from a normal aged population. Arch Gerontol Geriatr 19: 21-20.
14. Folstein MF, Folstein SE, Mc Hugh PR. 1975, 'Mini Mental State': a practical method for grading the cognitive state of outpatients for the clinician. J Psychiatr Res 12: 189-198.
15. Forette F, Seuz M, Staessen JA, et al., 2002. The prevention of dementia with antihypertensive treatment. Arch Intern Med 162: 2046-2052.
16. Grundman M, Petersen RC, Ferris SH, et al. 2004. Mild Cognitive Impairment can be distinguished from Alzheimer Disease and Normal Aging for clinical trials. Arch Neurol 61: 59-66.
17. Hamilton M. 1967. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278-293.
18. Hirawa N, Uehara Y, Kawabata Y, et al. 1999. Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats. Hypertension 34(3): 496-502.
19. Huges CP, Berg L, Danziger WL, et al. 1982. A new clinical scale for the staging of dementia. Br J Psychiatr 140: 566-572.
20. Larrieu S, Letenneur L, Orgogozo JM, et al. 2002. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 59: 1594-1599.
21. Lawton MP, Brody EM. 1969. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9: 179-186.
22. Luis CA, Loewenstein DA, Acevedo A, et al. 2003. Mild cognitive impairment: directions for future research. Neurology 26;61(4) Aug: 438-444.
23. Mahoney FI, Barthel DW. 1965. Functional evaluation: the Barthel index. Maryland State Med J 14: 61-65.
24. Malouf M, Grimley EJ, Areosa SA. 2003. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev (4): CD004514.
25. McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group. Neurology 34: 939-944.
26. Morris J, Storandt M, Miller JP, et al. 2001. Mild Cognitive impairment Represents Early-Stage Alzheimer Disease. Arch Neurol 58: 397-405.
27. Morris MC, Scherr PA, Hebert LE, et al. 2001. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol 58: 1640-1646.
28. Nilsson K, Gustafson L, Hultberg B. 2004. Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease. Int J Geriatr Psychiatry 19(7): 666-672.
29. Novelli G, Papagno C, Capitani E, et al. 1986. Tre tests clinici di ricerca e produzione lessicale. Taratura so soggetti normali. Archivi di Psicologia, Neurologia e Psichiatria 4: 477-506.
30. Ohrui T, Matsui T, Yamaya M, et al. 2004. Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan. J Am Geriatr Soc 52(4): 649-650.
31. Petersen RC, Thomas RG, Grundman M, et al. 2005. Vitamin E and Donepezil for the treatment of Mild Cognitive Impairment. N Engl J Med June 9. 352(23): 2379-2388.
32. Petersen RC. 2004. Challenges of epidemiological studies of Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 18(1): 1-2.
33. Quadri P, Fragiacomo C, Pezzati R, et al. 2004. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 80(1): 114-122.
34. Ravaglia G, Forti P, Maioli F, et al. 2004. Homocysteine and cognitive performance in healthy elderly subjects. Arch Gerontol Geriatr Suppl (9): 349-357.
35. Rozzini L, Vicini Chilovi B, Bellelli G, et al. 2005. Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy. Int J Geriatr Psychiatry 20: 547-551.
36. Salmon DP, Thomas RG, Pay MM, et al. 2002. Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology 59(7): 1022-1028.
37. Savaskan E, Hock C, Olivieri G, et al. 2001. Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia. Neurobiol Aging 22(4): 541-546.
38. Sheikh JI, Yesavage JA. 1986. Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version. Clinical gerontology: a guide to assessment and intervention. The Haworth Press: New York; 165-173.
39. Skoog I, Lernfelt B, Landahl S, et al. 1996. 15-year longitudinal study of blood pressure and dementia. Lancet 347: 1141-1145.
40. Statistical Package for the Social Sciences for Windows, release 11.5.1 (Italian version). SPSS Inc: 2002: Chicago, IL.
41. Staessen JA, Thijisq L, Fagard R, et al. 2004. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens 22(4): 847-857.
42. Tinetti ME. 1986. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 34: 119-126.
43. Tuokko H, Frerichs R, Graham J, et al. 2003. Five-year follow-up of cognitive impairment with no dementia. Arch Neurol 60: 577-582.
44. Voisin T, Touchon J, Vellas B. 2003. Mild Cognitive Impairment: a nosological entity? Curr Opin Neurol 16(Suppl 2): S43-45.